PAVMED INC. (NASDAQ:PAVM) Files An 8-K Material Modification to Rights of Security HoldersItem 3.03.
On May 15, 2018, the board of directors of PAVmed, Inc. (“PAVmed”) approved a reduction to the exercise price of PAVmed Inc.’s Series Z warrants (CUSIP number 70387R122) (the “Series Z Warrants”) that trade under the symbol “PAVMZ” on the Nasdaq Capital Market from $3.00 per share to $1.60 per share. Before this reduction takes effect, notice must first be provided to the current holders of Series Z Warrants. The effective date of the exercise price reduction will be June 1, 2018.
PAVmed Inc. issued a press release, filed as Exhibit 99.1, announcing the reduction to the exercise price of the Series Z Warrants.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits:
| Exhibit | Description |
| 99.1 | Press Release dated May 15, 2018 |
PAVmed Inc. ExhibitEX-99.1 2 ex99-1.htm Exhibit 99.1 PAVMED ANNOUNCES ADJUSTMENT TO SERIES Z WARRANT EXERCISE PRICE NEW YORK (May 15,…To view the full exhibit click here
